Clinical trial
Muscle Lactate and Lactate to Pyruvate Ratio Clearance as Useful Biomarkers for the Prediction of Mortality in Septic Shock Patients
NCT03700346 is registered in ClinicalTrials.gov with Military Hospital of Tunis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Muscle Lactate and Lactate to Pyruvate Ratio Clearance as Useful Biomarkers for the Prediction of Mortality in Septic Shock Patients
- Lead sponsor
- Military Hospital of Tunis
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2018
- Completion date
- December 31, 2018
- Enrollment
- 73 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
septic shock